Cocaine and Alcohol Awareness Program, Inc. (CAAP)

Located in Indio, CA, Cocaine and Alcohol Awareness Program, Inc. (CAAP) operates within the CA regulatory framework as a licensed addiction-treatment provider. The facility's programming is outpatient (Outpatient), not residential. Structural evaluation of this facility's clinical posture requires review of state licensing records, accreditation status, and payer-network contracts.

Care levels at Cocaine and Alcohol Awareness Program, Inc. (CAAP)

Cocaine and Alcohol Awareness Program, Inc. (CAAP) is an outpatient-focused program (Outpatient) — patients live at home or in sober living and attend treatment sessions. This level of care is clinically appropriate for mild-to-moderate substance use disorder, or for patients stepping down from residential. ASAM Criteria 4e level-of-care matching requires clinical assessment across six dimensions (withdrawal potential, biomedical conditions, emotional/behavioral/cognitive conditions, readiness, relapse risk, recovery environment). The alignment of Cocaine and Alcohol Awareness Program, Inc. (CAAP)'s offerings to any specific patient's clinical profile should be determined by an independent ASAM-aligned assessment prior to admission.

Insurance and payment

Payment and insurance posture: Payment and insurance specifics for Cocaine and Alcohol Awareness Program, Inc. (CAAP) are not fully documented in the SAMHSA registry — a direct admissions conversation is the reliable way to confirm what forms of payment are accepted and at what network-contract level. Pre-admission Verification of Benefits (VOB) documentation should include: specific plan product and network status, deductible status at time of admission, coinsurance rate applicable, prior authorization status and turnaround, and out-of-pocket accumulation. Under MHPAEA 2024 disclosure rules, plan-specific medical-necessity criteria must be available on request.

Before you call

Pre-admission due-diligence for Cocaine and Alcohol Awareness Program, Inc. (CAAP): (1) ASAM 4e level-of-care documentation matching clinical assessment; (2) written Verification of Benefits specific to insurance product; (3) MAT policy documentation (particularly buprenorphine and methadone continuation protocols for opioid use disorder patients); (4) accreditation verification via CARF or Joint Commission provider-search tools; (5) state licensing status confirmed via CA behavioral-health regulator inspection records. If the clinical situation involves opioid use disorder, confirm explicitly whether Cocaine and Alcohol Awareness Program, Inc. (CAAP) offers medication-assisted treatment — buprenorphine, methadone, or naltrexone. Programs that do not are operating outside the current standard of care.